Current perspectives for external control arms in oncology clinical trials: Analysis of EMA approvals 2016–2021
Author:
Publisher
Elsevier BV
Subject
Health Policy,Oncology
Reference34 articles.
1. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials;Schulz;BMJ,2010
2. The role of clinical trial participation in cancer research: barriers, evidence, and strategies;Unger;Am. Soc. Clin. Oncol. Educ. Book,2016
3. Real-world evidence in support of precision medicine: clinico-genomic cancer data as a case study;Agarwala;Health Aff.,2018
4. Randomized controlled trials versus real world evidence: neither magic nor myth;Eichler;Clin. Pharmacol. Ther.,2021
5. Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014;Hatswell;BMJ Open,2016
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The impact of different censoring methods for analyzing survival using real-world data with linked mortality information: a simulation study;BMC Medical Research Methodology;2024-09-13
2. Leveraging Real-World Evidence to Enhance Clinical Trials;Ophthalmology;2024-07
3. Quasi-experimental design for external control arm studies alongside single arm trials for regulatory purposes;Visualized Cancer Medicine;2024
4. Use of external control arms in immune-mediated inflammatory diseases: a systematic review;BMJ Open;2023-12
5. Matching by OS Prognostic Score to Construct External Controls in Lung Cancer Clinical Trials;Clinical Pharmacology & Therapeutics;2023-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3